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Background. Septal malalignment is related to erosion and device embolization in transcatheter closure of atrial septal defect
(ASD), but limited information is available. Objectives. *is study aimed to assess clinical significance of septal malalignment and
to determine appropriate evaluation of ASD diameter, including the selection of device size. Methods. Four hundred and
seventeen patients with ASD who underwent transcatheter closure were enrolled. Septal malalignment was defined as separation
between the septum primum and the septum secundum on transesophageal echocardiography. Results. One hundred and eighty-
four patients had septal malalignment. *e frequency of septal malalignment increased with age reaching around 50% in adult
patients. Septal malalignment was related to aortic rim deficiency.*e distance of separation between the septum primum and the
septum secundum was 5± 2mm (range, 1–11mm). In patients with septal malalignment, the ASD diameter measured at the
septum primumwas 19± 6mm, while the ASD diameter measured at the septum secundumwas 16± 6mm.*ere was a difference
of 4± 2mm (range, 0–8mm) between the ASD diameter measured at the septum primum and that measured at the septum
secundum. For transcatheter closure, the Amplatzer Septal Occluder device size 2-3mm larger and the Occlutech Figulla Flex II
device size 4–7mm larger than the ASD diameter measured at the septum primumwere frequently used. During the study period,
erosion or device embolization did not occur in all of the patients. Conclusions. Septal malalignment is highly prevalent in adult
patients with aortic rim deficiency. *e measurement of ASD diameter at the septum primum can be valuable for the selection of
device size in patients with septal malalignment.
1. Introduction
Transcatheter closure has been established as an effective
treatment for atrial septal defect (ASD) and has become an
alternative to surgical closure [1–6]. Although trans-
catheter closure is safe, serious complications such as
erosion and device embolization occur. *e etiology of
these complications is multifactorial. A deficient aortic rim
and over- and/or undersized device use have been impli-
cated as risk factors [7]. Recently, some studies have fo-
cused on the relationship of septal malalignment with
erosion and device embolization [8–10]. In septal mala-
lignment, the septum primum is malaligned toward the left
atrial side and is separated from the septum secundum. To
prevent the complications, the recognition of the presence
of septal malalignment is important. Accurate evaluation of
ASD diameter is also necessary. To stably deploy the device,
the left atrial disc is needed to be placed at the septum
primum, and the right atrial disc is needed to be placed at
the septum secundum.*us, ASD diameter is considered to
be measured at the point of the septum primum. However,
septal malalignment has not been fully investigated.
*erefore, this study aimed to assess clinical significance of
septal malalignment and to determine appropriate evalu-
ation of ASD diameter, including the selection of device
size.
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2. Methods
2.1. Study Population. *e study population comprised 417
consecutive patients with ASD who underwent transcatheter
closure from November 2011 to September 2018 in our
institution. Indications for transcatheter closure were a
significant left-to-right shunt, right ventricular volume
overload, and/or clinical symptoms of heart failure. Patients
with multifenestrated defects, other congenital heart disease,
or the status of postsurgical repair for defect were excluded.
All patients gave written informed consent for the proce-
dure.*e study was approved by the ethics committee of our
institution.
2.2. Septal Malalignment. All patients underwent trans-
esophageal echocardiography (TEE) (iE33; Philips Medical
Systems, Andover, MA, USA) before and during the pro-
cedure. TEE evaluated ASD morphology with sweeping
from 0 to 180 degrees, including imaging at 0, 30, 45, 60, 75,
90, 120, 135, and 150 degrees. Septal malalignment was
defined as the separation between the septum primum and
the septal secundum on the aortic wall. Septal malalignment
was evaluated in the short-axis aortic view from 0 to 45
degrees. To detect the presence of septal malalignment, we
investigated whether the septum attached to the aorta was
separated on TEE. When the septum primum was mala-
ligned toward the left atrial side and the separation of the
septum primum and the septum secundum was observed
[10], the patient was diagnosed as having septal malalign-
ment. *e ASD diameter was determined at the point of the
septum primum but not at the point of the septum
secundum (Figure 1). For the severity of septal malalign-
ment, the distance of separation between the septum pri-
mum and the septum secundum was assessed.
2.3. Transcatheter Closure. Transcatheter closure was per-
formed under TEE guidance as described previously [11]
using the Amplatzer Septal Occluder device (Abbott, Chi-
cago, IL, USA) and the Occlutech Figulla Flex II device
(Occlutech GmbH, Jena, Germany). *e device size was
selected on the basis of the maximal ASD diameter evaluated
by TEE.
2.4. Study Design. *is was an observational cohort study.
First, we investigated the incidence and severity of septal
malalignment and the morphological characteristics related
to septal malalignment. Second, we assessed whether the
evaluation of ASD diameter at the point of the septum
primum was appropriate, including the selection of device
size. Because septal malalignment was observed from 0 to 45
degrees on TEE, 329 patients who had the maximal diameter
of ASD within these degrees were included in this analysis.
2.5. Statistical Analysis. Data are presented as mean-± standard deviation for continuous variables and as
number and percentage for categorical variables. Differences
between the two groups were analyzed by the t-test and
Mann–WhitneyU test for continuous variables and the χ [2]
test for categorical variables. Relationship between the se-
verity of septal malalignment and hemodynamics was
assessed by Pearson’s correlation coefficient. Statistical
analysis was performed with JMP version 14.2 (SAS Institute
Inc., Cary, NC, USA), and significance was defined as a value
of P< 0.05.
3. Results
3.1. Clinical Characteristics. *e mean age of the patients
was 49 ± 22 years (range, 6–88 years). Septal malalignment
was observed in 184 (44%) patients. Comparisons of
clinical characteristics between patients with septal mala-
lignment and those without septal malalignment are shown
in Table 1. Patients with septal malalignment were older
than those without septal malalignment. Aortic rim defi-
ciency, which was defined as <5mm, was observed more
frequently in patients with septal malalignment than in
those without septal malalignment. Pulmonary-to-systemic
blood flow ratio was higher in patients with septal mala-
lignment than in those without septal malalignment. *e
frequency of septal malalignment according to age is shown
in Figure 2. Almost 50% of patients ≥21 years old had septal
malalignment, while septal malalignment was observed in
16 (32%) of 50 patients aged 11–20 years and in three (14%)
of 22 patients aged ≤10 years.*is frequency increased with
age until adulthood. *e distance of separation between the
septum primum and the septum secundum is shown in
Figure 3. *e mean distance of separation was 5± 2mm
(range, 1–11mm). *e distance of separation of ≥10mm
was observed in some patients. *e distance of separation
was related to pulmonary-to-systemic blood flow ratio
(R � 0.14, P< 0.001).
3.2. Evaluation of Atrial Septal Defect Diameter. Among 329
patients who had the maximal diameter of ASD from 0 to 45
degrees, 166 patients had septal malalignment. *e ASD
Figure 1: Transesophageal echocardiography showing septal
malalignment. *e septum primum attached to the aorta is
malaligned toward the left atrial side (solid arrow). *e septum
primum is separated from the septum secundum (dotted arrow).
*e defect surface of the septum primum (solid line) is different
from that of the septum secundum (dotted line). *e distance of
separation between the septum primum and the septum secundum
is measured (double arrow).
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diameter and the device selection in patients with septal
malalignment are shown in Table 2. *e ASD diameter
measured at the septum primum was 19± 6mm, while the
ASD diameter measured at the septum secundum was
16± 6mm. *ere was a difference of 4± 2mm (range,
0–8mm) between the ASD diameter measured at the septum
primum and that measured at the septum secundum. *e
Amplatzer Septal Occluder device was used in 103 patients
with septal malalignment. *e device size was 22± 7mm.
*e difference between the device size and the ASD diameter
measured at the septum primum was 2± 1mm, and the
device size 2-3mm larger than the ASD diameter was
frequently used (Figure 4(a)). *e Occlutech Figulla Flex II
device was used in 63 patients with septal malalignment.*e
device size was 24± 5mm.*e difference between the device
size and the ASD diameter measured at the septum primum
was 5± 1mm, and the device size 4–7mm larger than the
ASD diameter was frequently used (Figure 4(b)). During the
study period, erosion or device embolization did not occur
in all of the patients.
4. Discussion
*e major findings of the present study were (1) septal
malalignment was frequently observed, (2) the incidence of
septal malalignment increased with age until adulthood, (3)
septal malalignment was related to aortic rim deficiency, and
(4) the measurement of ASD diameter at the septum pri-
mum on TEE and the selection of device size based on the
ASD diameter were appropriate in patients with septal
malalignment. To the best of our knowledge, this is the first
study to show the clinical significance of septal malalign-
ment, including the appropriate evaluation of ASD diameter
for transcatheter closure.
4.1. Clinical Importance of Septal Malalignment. Serious
complications such as erosion and device embolization are
rare but fatal. With regard to ASD morphology, a deficient
rim increases the risk of these complications [7, 12] but is a
common finding [13]. *erefore, other morphological
factors in addition to a deficient rim may be important.
Recently, septal malalignment has been proposed as a novel
risk factor [8, 9]. Although the aortic rim is usually in the
middle of the aorta in the short-axis view on TEE, the
septum primum attached to the aorta is malaligned toward
the left atrial side in septal malalignment. *e septum
primum and the septum secundum are separated, resulting
in a difference in defect surfaces of the septum primum and
the septum secundum. At the time of transcatheter closure,
septal malalignment could cause a change in the device axis
Table 1: Clinical characteristics.
Malalignment (+) (n� 184) Malalignment (− ) (n� 233) P value
Age (years) 52± 19 46± 24 0.02
Female 104 (57%) 144 (62%) 0.28
Aortic rim deficiency 173 (94%) 135 (58%) <0.001
Pulmonary-to-systemic blood flow ratio 2.4± 0.9 2.1± 0.7 <0.001
Pulmonary arterial pressure (mmHg) 18± 7 18± 7 0.94
Data are presented as mean± standard deviation.
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Figure 2: Frequency of septal malalignment. *e frequency of
septal malalignment according to age is shown.
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Figure 3: Severity of septal malalignment. *e distance of sepa-
ration between the septum primum and the septum secundum in
patients with septal malalignment is shown.
Table 2: ASD diameter and device size in 166 patients with septal
malalignment.
ASD diameter at the septum primum (mm) 19± 6
ASD diameter at the septum secundum (mm) 16± 6
Amplatzer Septal Occluder device 103 (62%)
Device size (mm) 22± 7
Occlutech Figulla Flex II device 63 (38%)
Device size (mm) 24± 5
Data are presented as mean± standard deviation. ASD, atrial septal defect.
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angle against the aorta, inducing the potential for pushing
the device disc to the aorta and instability of deploying the
device. *is leads to the occurrence of erosion and device
embolization. We previously reported one patient who had
erosion 3 days after the procedure [10]. *e patient had
septal malalignment combined with aortic rim deficiency.
Additionally, we experienced two patients for whom the
device was not embolized but was unstably deployed. In
both patients, we did not notice that the septum primum
was malaligned toward the left atrial side on TEE during the
procedure. *is led to underestimation of the maximal
ASD diameter, resulting in undersized device use. *ere-
fore, the recognition of septal malalignment on TEE was
considered to be important in performing transcatheter
closure. However, limited information is available re-
garding septal malalignment. Septal morphology has not
been well evaluated by TEE, even in the studies that
assessed the risk factors of erosion and device embolization
[13–15].
*e present study showed that septal malalignment
was not uncommon in adult patients with ASD. Septal
malalignment was related to aortic rim deficiency. *e
severity of septal malalignment was widely varied. By
focusing on the septum primum and the septum secun-
dum attached to the aorta during TEE, 1 or 2mm septal
malalignment could be assessed. Our results are useful
when evaluating ASD morphology for deploying the
device stably in transcatheter closure. Additionally, the
present study found that the frequency of septal mala-
lignment increased with age until adulthood. *e severity
of septal malalignment was related to pulmonary-to-
systemic blood flow ratio. Left atrial size is determined by
body size. Left atrium enlarges in response to volume
overload [16]. Based on these findings, septal malalign-
ment may be a secondary change associated with the
dilatation of the left atrium which is induced by chronic
volume overload due to ASD.
4.2. Evaluation of Septal Malalignment for Transcatheter
Closure. *e accurate measurement of ASD diameter on
TEE, leading to the optimal selection of device size, is es-
sential to perform transcatheter closure. However, no
studies have focused on how to evaluate the ASD diameter in
patients with septal malalignment. To stably deploy the
device, the device must enclose the septum primum and the
septum secundum in between both discs, without either the
disc being wedged in between the two septa. If the device
encloses only the septum primum or the septum secundum,
either the disc wedges into the aortic wall, leading to an
increased risk for erosion and device embolization. In the
present study, the ASD diameter was measured at the point
of the septum primum on TEE in patients with septal
malalignment, and the device size was selected based on the
ASD diameter. Although our study population was relatively
high risk, erosion or device embolization did not occur,
indicating that the evaluation of ASD diameter was ap-
propriate. Furthermore, the present study revealed that the
device size 2-3mm larger than the ASD diameter in the
Amplatzer Septal Occluder device and 4–7mm larger than
the ASD diameter in the Occlutech Figulla Flex II device can
work well in the range of defects we occluded.
4.3. Clinical Implications. Transcatheter closure has become
an alternative to surgical closure because of less invasiveness
and a shorter hospital stay [3–5]. Transcatheter closure
should be performed without any complications. To achieve
this goal, accurate evaluation of ASD morphology by TEE
and the optimal selection of device size are essential. *e
present study indicates that the recognition of the presence
of septal malalignment is important, especially in adult
patients with aortic rim deficiency. In patients with septal
malalignment, the ASD diameter should be measured at the
septum primum but not at the septum secundum, which
results in the optimal selection of device size. *e present
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Figure 4: Difference between the ASD diameter and the device size in patients with septal malalignment. *e difference between the ASD
diameter measured at the septum primum and Amplatzer Septal Occluder device size (a) and the Occlutech Figulla Flex II device size (b).
ASD, atrial septal defect.
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study provides evidence for the therapeutic strategy in pa-
tients with ASD combined with septal malalignment.
4.4. Study Limitations. *ere are limitations in the present
study. First, this study was a small number of patients to
assess the association between septal malalignment and the
occurrence of erosion and device embolization. Large
studies are required to confirm our findings. Second, the
follow-up period was not long. Finally, there was selection
bias because patients who underwent transcatheter closure
were enrolled. Severe septal malalignment which could not
be performed transcatheter closure might not be included.
5. Conclusions
Septal malalignment is highly prevalent, especially in adult
patients with aortic rim deficiency. *e measurement of
ASD diameter at the septum primum on TEE can be valuable
for the selection of device size in patients with septal
malalignment.
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